Notes to the financial statements
1 Accounting Principles
General approach
The annual financial statements of Bellevue Group AG were prepared in accordance with the guidelines of the Swiss Code of Obligations. Balance sheet items are valued at historical costs.
Cash and cash equivalents, receivables and liabilities
Assets are recognized at acquisition costs and liabilities are recognized at their nominal value. Specific valuation adjustments are made for identifiable risks of loan losses.
Participations
Participations are recognized at acquisition costs less impairments necessary for commercial reasons.
Accruals and deferrals
Accruals and deferrals are expenditures of the current financial year, which are recognized as expenses in the subsequent financial year as well as revenues of the current financial year, which are recognized as income in the subsequent financial year.
Treasury shares
Treasury shares are recognized at acquisition cost and deducted from shareholders’ equity at the time of acquisition. In case of a resale, the gain or loss is recognized through the income statement as profit or loss. For treasury shares held by subsidiaries, a reserve for treasury shares is booked to the value of the acquisition price.
Waiver of cash flow statement, management report and additional disclosures in the notes
As Bellevue Group AG has prepared its consolidated financial statements in accordance with a recognized accounting standard (IFRS), it has decided to waive the disclosure of additional information on audit fees in the notes, the management report as well as a the cash flow statement in accordance with the law.
2 Notes to the financial statements
Cash and cash equivalent
CHF 1 000 | 31.12.2025 | 31.12.2024 | ||
Due from banks | 1 621 | 3 263 | ||
Total | 1 621 | 3 263 |
Other short-term receivables
CHF 1 000 | 31.12.2025 | 31.12.2024 | ||
Due from group companies | 6 077 | 5 972 | ||
Due from third parties | 14 | 33 | ||
Total | 6 091 | 6 005 |
Other short-term receivables from group companies include short-term loans and bore interest of 1.50% in the financial year (2024: 1.50%). The recorded interest is shown in the position «Finance income».
Participations
31.12.2025 | 31.12.2024 | |||||||||||||
Company | Domicile | Purpose | Currency | Share capital/Nominal capital | Capital | Voting rights | Capital | Voting rights | ||||||
Bellevue Asset Management AG | Zurich, Switzerland | Asset Management | CHF | 1 750 000 | 100% | 100% | 100% | 100% | ||||||
Bellevue Asset Management (Deutschland) GmbH | Frankfurt am Main, Germany | Asset Management | EUR | 540 000 | 100% | 100% | 100% | 100% | ||||||
Bellevue Asset Management (UK) Limited | London, UK | Asset Management | GBP | 50 000 | 100% | 100% | 100% | 100% | ||||||
Bellevue Asset Management (Singapore) Pte Ltd | Singapore | Distribution | SGD | 1 000 000 | 100% | 100% | 100% | 100% | ||||||
Asset Management BaB N.V. | Curaçao | Asset Management | USD | 6 001 | 100% | 100% | 100% | 100% | ||||||
Bellevue Research Inc. | New York, USA | Research | USD | 100 | 100% | 100% | 100% | 100% | ||||||
Bellevue Private Markets AG | Zurich, Switzerland | Investment Advisor | CHF | 1 000 000 | 100% | 100% | 100% | 100% | ||||||
Bellevue Komplementär AG | Zurich, Switzerland | Asset Management | CHF | 200 000 | 100% | 100% | 100% | 100% | ||||||
Bellevue Private Markets Management I S.à.r.l. | Luxembourg | Asset Management | EUR | 12 000 | 100% | 100% | 100% | 100% | ||||||
adbodmer AG 1) | Zug, Switzerland | Investment Advisor | CHF | 100 000 | 0% | 0% | 100% | 100% | ||||||
BB Biotech Ventures GP 2) | Guernsey | Investment Advisor | GBP | 10 000 | 0% | 0% | 100% | 100% | ||||||
1) The company was sold on September 30, 2025.
2) The company was liquidated on August 18, 2025.
As a rule, participations are valued individually. For participations that are already managed and assessed together as an economic business unit within the company, the impairment test of the participations is performed analogously to the IFRS consolidated financial statements at the level of the economic business units.
Impairment of participations
During the financial year, Bellevue Private Markets AG sold its participation in adbodmer AG. As a result of the discontinuation of its operating activities, an impairment of the carrying amount of the participation was required as at December 31, 2025. Consequently, the investment in Bellevue Private Markets AG was impaired by CHF 7.5 mn.
Other short-term liabilities
CHF 1 000 | 31.12.2025 | 31.12.2024 | ||
Due to group companies | – | 665 | ||
Due to third parties | 3 | 32 | ||
Total | 3 | 697 |
Treasury shares
Treasury shares are held directly by the Company. All transactions are carried out at market prices.
Average price in CHF | Number of shares | |||
Balance as of 1.1.2024 | 305 473 | |||
Purchases | 17.5685 | 5 661 | ||
Disposals | 19.0471 | – 134 225 | ||
Balance as of 31.12.2024 | 176 909 | |||
Purchases | 16.1785 | 67 289 | ||
Disposals | 8.4054 | – 162 541 | ||
Balance as of 31.12.2025 | 81 657 |
Disposals and purchases of treasury shares also include any deliveries or returns of treasury shares as part of share-based payments, which are not cash-effective in such cases.
3 Additional Information
Company name, legal form and domicile
The Bellevue Group AG is a joint stock company under the Swiss Code of Obligations and is domiciled in 8700 Küsnacht at Seestrasse 16. As of January 1, 2025, the head office will be relocated to Theaterstrasse 12, 8001 Zurich, Switzerland.
Declaration on FTEs
The annual average of full-time employees has not exceeded 10 in the current financial year (previous year: not exceeded 10).
Information on shareholdings of members of the Board of Directors and the Group Executive Board
31.12.2025 | 31.12.2024 | |||
Shares | Shares | |||
Share-holdings of members of the Board of Directors | ||||
Veit de Maddalena, Executive Chairman 1) | 292 468 | 275 189 | ||
Urs Schenker, Member | 58 160 | 32 068 | ||
Katrin Wehr-Seiter, Member | 35 683 | 25 164 | ||
Barbara Angehrn Pavik, Member | 20 593 | 10 111 | ||
Share-holdings of members of the Group Executive Board | ||||
Veit de Maddalena, Executive Chairman 1) | 292 468 | 275 189 | ||
Markus Peter, CEO Bellevue Asset Management AG | 194 321 | 174 832 | ||
Stefano Montalbano, CFO/CRO | 23 733 | 16 861 | ||
Patrick Fischli, Head Distribution 2) | n/a | 55 452 | ||
Fabian Stäbler, COO 2) | n/a | – | ||
Gebhard Giselbrecht, CEO 2) | n/a | 44 403 |
1) The above table includes all participations across functions.
2) Gebhard Giselbrecht resigned from the Group Executive Board on June 2, 2025, and left Bellevue Group on August 31, 2025. Patrick Fischli and Fabian Stäbler resigned from the Group Executive Board on December 2, 2025.
Events after the balance sheet date
No events have occurred since the balance sheet date that would have a material impact on the information provided in the year 2025 financial statements and would therefore need to be disclosed.
Information on major shareholders
Based on the notifications received and published by Bellevue Group AG, each of the following parties owns significant voting rights:
31.12.2025 | 31.12.2024 | |||||||
Shareholder or beneficial owner | Voting rights held | Number of shares | Voting rights held | Number of shares | ||||
Martin Bisang, Küsnacht | 23.91% | 3 218 400 | 23.91% | 3 218 400 | ||||
Hansjörg Wyss, Cambridge MA (USA) | 9.66% | 1 300 000 | 9.66% | 1 300 000 | ||||
Jürg and Manuela Schäppi, Rapperswil-Jona | 9.18% | 1 235 299 | 9.18% | 1 235 299 | ||||
4 Proposal to the Annual General Meeting
CHF 1 000 | Proposal of the Board of Directors 2026 | Resolution of the AGM 2025 | ||
Profit for the year | – 2 227 | 16 931 | ||
Balance brought forward from previous year | 90 634 | 83 003 | ||
Total Profit | 88 407 | 99 934 | ||
Dividend on eligible capital 1) | – 2 019 | – 9 300 | ||
Balance carried forward to new financial year | 86 388 | 90 634 |
1)Including treasury shares possibly held directly by Bellevue Group AG.
Upon approval of this proposal, the dividend of CHF 0.15 per registered share of CHF 0.10 will be paid less the federal withholding tax of 35%.